Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vyant Bio Inc (VYNT)

Vyant Bio Inc (VYNT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vyant Bio Inc 2370 State Route 70 Suite 310 Cherry Hill NJ 08002 USA

P: 201-479-8126

Description:

VYANT BIO INC. operates through wholly-owned subsidiaries, StemoniX and vivoPharm. StemoniX is empowering the discovery of new medicines through the convergence of novel human biology and software technologies. vivoPharm offers proprietary preclinical test systems supporting clinical diagnostic offerings at early stages valued by the pharmaceutical industry, biotechnology companies, and academic research centers. VYANT BIO INC., formerly known as Cancer Genetics Inc., is based in CHERRY HILL, N.J.

Key Statistics

Overview:

Market Capitalization, $K 66,088
Shares Outstanding, K 28,986
Annual Sales, $ 5,750 K
Annual Net Income, $ -8,000 K
Last Quarter Sales, $ 1,950 K
Last Quarter Net Income, $ -4,190 K
60-Month Beta 2.41
% of Insider Shareholders 15.00%
% of Institutional Shareholders 7.83%
Float, K 24,638
% Float 85.00%

Growth:

1-Year Return -43.20%
3-Year Return -92.50%
5-Year Return -95.54%
5-Year Revenue Growth -68.13%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/16/21
Earnings Per Share ttm -1.57
EPS Growth vs. Prev Qtr 83.53%
EPS Growth vs. Prev Year 82.93%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 10/25/19

VYNT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -35.03%
Return-on-Assets % -29.85%
Profit Margin % -139.13
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 11.39
Price/Cash Flow N/A
Price/Book 1.28
Book Value/Share 2.07
Interest Coverage -28.78
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar